Efficacy and Adverse Event Profile in Patients Receiving “Shorter Oral Bedaquiline-containing Multidrug-resistant/Rifampicin-resistant Tuberculosis Regimen” in a Tertiary Care Hospital in Eastern India

Introduction: Multidrug resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) is a leading cause of death in India. To combat this, National TB Elimination Programme, erstwhile RNTCP) has launched “shorter oral bedaquiline (Bdq)-containing MDR/RR-TB regimen” from March 2021 replacing the injectabl...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hindol Mondal, Manasi Basu Banerjee, Abheek Das, Somnath Maity
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-07-01
Series:	Journal of Advanced Lung Health
Subjects:	adverse events bedaquiline multidrug-resistant/rifampicin-resistant tuberculosis
Online Access:	https://journals.lww.com/10.4103/jalh.jalh_64_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients
by: Oki Nugraha Putra, et al.
Published: (2024-12-01)

Clinical Profiles of Multidrug-Resistant and Rifampicin-Monoresistant Tuberculosis in Korea, 2018–2021: A Nationwide Cross-Sectional Study
by: Jinsoo Min, et al.
Published: (2025-01-01)

Treatment success and mortality among people with multi-drug resistant and rifampicin resistant-tuberculosis on bedaquiline-based regimen at three referral hospitals in Uganda: A retrospective analysis
by: Lodiong Jackson Dumo Lodiong, et al.
Published: (2024-12-01)

Bedaquiline resistance in Mycobacterium tuberculosis during antimycobacterial therapy and its impact on clinical outcomes (clinical cases)
by: O. M. Raznatovska, et al.
Published: (2023-03-01)

Evaluation of a modified short all oral treatment regimen for rifampicin-multidrug resistant tuberculosis in Dominican Republic
by: María Rodríguez, et al.
Published: (2025-02-01)

Adverse Drug Reactions in Multidrug-resistant Tuberculosis Patients on Longer Bedaquiline-based Regimen at a Tertiary Care Center in Mumbai
by: Abhishek Saini, et al.
Published: (2025-07-01)

Non-inferiority stepped wedge cluster randomized controlled trial on all-oral shorter regimens for rifampicin resistant/multidrug-resistant TB in Pakistan – a study protocol
by: Nida Khan, et al.
Published: (2025-05-01)

New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline
by: Ekaterina Sokolskaya, et al.
Published: (2024-12-01)

Carriage of Rifampicin- and Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in Apparently Healthy Camels: A View Through a Zoonosis Lens
by: Dalia Hamza, et al.
Published: (2025-05-01)

Impact of Patient-Centered Care on Treatment Outcomes of Multidrug-Resistant/Rifampicin-Resistant Tuberculosis in Xi’an
by: Luo H, et al.
Published: (2025-03-01)

Prevalence of bedaquiline resistance in patients with drug-resistant tuberculosis: a systematic review and meta-analysis
by: Xinyang Hu, et al.
Published: (2025-05-01)

Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya
by: Albert Okumu, et al.
Published: (2024-12-01)

Health-related quality of life of patients with rifampicin-resistant/multidrug-resistant tuberculosis in Vietnam: a prospective follow-up study
by: Nguyen Vu Anh Thu, et al.
Published: (2025-07-01)

GENE MUTATION PATTERNS OF RIFAMPICIN IN MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS COMPLEX STRAINS
by: Esra Yıldırım Servi, et al.
Published: (2022-03-01)

Beyond treatment and cure: Burden of adverse drug reactions in a case of multidrug-resistant tuberculosis
by: Sagarika N. Suresh, et al.
Published: (2025-01-01)

Use of bedaquiline in the chemotherapy regimen for multiple drug resistant tuberculosis in the HIV positive patient
by: N. D. Pirogova, et al.
Published: (2019-11-01)

Outbreak Caused by Multidrug-Resistant Mycobacterium Tuberculosis with Unusual Combination of Resistance Mutations, Northern Argentina, 2006–2022
by: Roxana Paul, et al.
Published: (2025-03-01)

Treatment Outcomes for Drug-Resistant Tuberculosis Patients on Bedaquiline-Based Regimens in a Mostly Rural South Africa
by: Rukasha I, et al.
Published: (2025-04-01)

Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran
by: Nazanin Ahmad Khosravi, et al.
Published: (2025-08-01)

Evaluation of Safety of 9- and 6-Month Treatment Regimens in Patients with Rifampicin-Resistant Tuberculosis in the Republic of Belarus
by: N. V. Yatskevich, et al.
Published: (2024-03-01)

Guanethidine Enhances the Antibacterial Activity of Rifampicin Against Multidrug-Resistant Bacteria
by: Xiaoou Zhao, et al.
Published: (2024-10-01)

Bedaquiline and linezolid regimens for multidrug-resistant tuberculosis: a systematic review and meta-analysis
by: Mahdis Cheraghi, et al.
Published: (2025-03-01)

Evaluation of Effectiveness of 9- and 6-Month Treatment Regimens in Patients with Multiple Drug Resistant or Rifampicin-Resistant Tuberculosis in the Republic of Belarus
by: N. V. Yatskevich, et al.
Published: (2023-12-01)

Effectiveness of a bedaquiline, linezolid, clofazimine ‘core’ for multidrug-resistant TB
by: C. Zeng, et al.
Published: (2025-05-01)

Factors associated with unfavourable treatment outcomes among patients with Multidrug-resistant Tuberculosis receiving outpatients care
by: Maria Jose Vadakunnel, et al.
Published: (2025-08-01)

Immediate and Postponed Results of Short-Course Chemotherapy Regimens Containing Bedaquiline in Tuberculosis Patients with Multiple Drug Resistance
by: P. N. Golubchikov, et al.
Published: (2023-08-01)

Real World Experience of Bedaquiline-Based Anti-Tubercular Regime in Multi-Drug Resistant Tuberculosis.
by: Vikas Marwah, et al.
Published: (2025-01-01)

Predictors of early and interim culture un-conversion in multidrug-resistant/rifampicin-resistant tuberculosis: a retrospective multi-center cohort study in China
by: Qing Chen, et al.
Published: (2024-10-01)

Bedaquiline Effect on QT Interval of Drugs-Resistant Tuberculosis Patients: Real World Data
by: I Gusti Agung Ayu Putu Sri Darmayani, et al.
Published: (2022-09-01)

Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases
by: A. A. Akzhigitova, et al.
Published: (2022-05-01)

Clinical efficacy and computed tomography diagnostic value of bedaquiline‐containing regimens in the treatment of drug‐resistant pulmonary tuberculosis
by: Saiduo Liu, et al.
Published: (2024-09-01)

Evaluation of the Gene Xpert Mycobacterium tuberculosis/resistance to rifampicin assay in rapid diagnosis of tuberculosis and identification of rifampin resistance in tuberculous patients
by: Amal H.G. Hamed, et al.
Published: (2025-01-01)

EXPERIENCE OF USING BEDAQUILINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS WITH MULTIPLE ANDEXTENSIVE DRUG RESISTANCE
by: N. M. Konovаlovа, et al.
Published: (2018-01-01)

Recent advancements in tuberculosis (TB) treatment regimens
by: Shyamala Ravikoti, et al.
Published: (2025-02-01)

Treatment outcomes in cavitary multidrug-resistant/rifampicin-resistant tuberculosis and risk factors for cavity closure: a retrospective cohort study in Southwest China
by: Qing Chen, et al.
Published: (2025-07-01)

High Prevalence of atpE Mutations in Bedaquiline-Resistant Mycobacterium tuberculosis Isolates, Russia
by: Danila Zimenkov, et al.
Published: (2025-03-01)

Efficacy and safety of bedaquiline in treatment regimens in patients TB/HV co-infection in the Udmurt Republic
by: O. E. Russkikh, et al.
Published: (2023-04-01)

Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance
by: N. Yu. Nikolenko, et al.
Published: (2023-07-01)

Distribution of Minimum Inhibitory Concentrations and Resistance-associated Gene Mutations in Multidrug-resistant Mycobacterium tuberculosis Strains from Southern Türkiye: Insights on Bedaquiline, Delamanid, and Linezolid
by: Huda Ahmed, et al.
Published: (2024-12-01)

Experience of using two courses of bedaquiline in the adolescent with extensive drug resistant fibrous cavernous tuberculosis
by: L. V. Pаnovа, et al.
Published: (2019-08-01)